Information:
Fel:
ID
45582
Beskrivning
Principal Investigator: Charles Perou, PhD, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill,Chapel Hill, NC, USA MeSH: Breast Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000676 The goal of this study is to study gene expression patterns in tumors, normal tissues, and cell lines.
Länk
Nyckelord
Versioner (1)
- 2023-01-25 2023-01-25 - Chiara Middel
Rättsinnehavare
Charles Perou, PhD, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill,Chapel Hill, NC, USA
Uppladdad den
25 januari 2023
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000676 Sequence-Based Analysis of Human Breast Tumors
Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- StudyEvent: SEV1
- Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, sample ID, and sample use variable of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, age, race, survival event, tumor characteristics including ER, PR, HER2 status, and PAM50 subtype, tumor size, grade, M stage, and nodule status of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID and GEO accession ID of samples obtained from participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID, analyte type, body site where sample was obtained, protocols to extract total RNA, cell or tissue type of sample, tumor status of sample, protocols to remove rRNA from sequencing library, primary tumor, metastasis, or transformed cell line, primary tumor location, sequencing center, tissue type to extract total RNA for library construction, tumor grade, tumor stage, and tumor treatment of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
Similar models
Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- StudyEvent: SEV1
- Subject ID, affection status, and consent group of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, sample ID, and sample use variable of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Subject ID, age, race, survival event, tumor characteristics including ER, PR, HER2 status, and PAM50 subtype, tumor size, grade, M stage, and nodule status of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID and GEO accession ID of samples obtained from participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
- Sample ID, analyte type, body site where sample was obtained, protocols to extract total RNA, cell or tissue type of sample, tumor status of sample, protocols to remove rRNA from sequencing library, primary tumor, metastasis, or transformed cell line, primary tumor location, sequencing center, tissue type to extract total RNA for library construction, tumor grade, tumor stage, and tumor treatment of participants with breast cancer and involved in the "Sequence-Based Analysis of Human Breast Tumors" project.
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
SUBJECT_ID
Item
Subject ID
string
C2348585 (UMLS CUI [1,1])
Item
Consent group as determined by DAC
text
C0021430 (UMLS CUI [1,1])
C0441833 (UMLS CUI [1,2])
C0441833 (UMLS CUI [1,2])
CL Item
General Research Use (MDS) (GRU-MDS) (1)
C0021430 (UMLS CUI [1,1])
C0242481 (UMLS CUI [1,2])
C0242481 (UMLS CUI [1,2])
CL Item
Disease-Specific (Cancer, MDS) (DS-CA-MDS) (2)
CL Item
Control (1)
C3274648 (UMLS CUI [1,1])
CL Item
Case (2)
C3274647 (UMLS CUI [1,1])
CL Item
Other (3)